This compound is a pharmaceutical intermediate used in the synthesis of lansoprazole. It appears as a salt-like form of a pyridine derivative containing a chloromethyl group and a trifluoroethoxy substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride
pharmaceutical intermediate
Tert-butyl (3R,4R)-3-amino-4-fluoropiperidine-1-carboxylate
pharmaceutical intermediate
(S)-4-(TERT-BUTOXYCARBONYL)-1,4-OXAZEPANE-2-CARBOXYLIC ACID
pharmaceutical intermediate
4-(2-Pyridinyl)benzaldehyde
pharmaceutical intermediate
(R)-3-[(Methylsulfonyl)oxy]pyrrolidine-1-carboxylic acid tert-butyl ester
pharmaceutical intermediate
The international HS code for 2-(Chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hydrochloride (CAS 127337-60-4) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-(chloromethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine;hydrochloride
CMZBQUWICURDCD-UHFFFAOYSA-N
CC1=C(C=CN=C1CCl)OCC(F)(F)F.Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.